Brunn Carsten (CIK 0001760229)

Latest company ownership

Shares held
204,096
Last filed at
Jan 7, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 3, 2025 Jan 7, 2025 Cartesian Therapeutics, Inc. CEO Sell 40.0 -17,271 -7.80% ✗ $289.8K
Nov 13, 2023 Nov 15, 2023 Cartesian Therapeutics, Inc. CEO Sell 17.5 -521,125 -66.55% ✗ $1.1M
Sep 25, 2023 Sep 26, 2023 Cartesian Therapeutics, Inc. CEO Sell 52.5 -2,932 -0.37% ✗ $3.1K
Jan 4, 2023 Jan 6, 2023 Cartesian Therapeutics, Inc. CEO Sell 46.3 -41,070 -4.97% ✗ $46.5K
Dec 5, 2022 Dec 7, 2022 Cartesian Therapeutics, Inc. CEO Sell 50.0 -4,522 -0.82% ✗ $6K
Sep 28, 2022 Sep 30, 2022 Cartesian Therapeutics, Inc. CEO Sell 52.5 -2,692 -0.50% ✗ $4.5K
Sep 1, 2022 Sep 6, 2022 Cartesian Therapeutics, Inc. CEO Sell 50.0 -4,768 -0.87% ✗ $8.8K
Mar 1, 2022 Mar 3, 2022 Cartesian Therapeutics, Inc. CEO Sell 47.5 -5,443 -1.03% ✗ $9.9K
Jan 5, 2022 Jan 7, 2022 Cartesian Therapeutics, Inc. CEO Sell 46.3 -13,597 -2.56% ✗ $42K
Dec 10, 2021 Dec 14, 2021 Cartesian Therapeutics, Inc. CEO Sell 42.5 -17,196 -5.33% ✗ $51.4K
Dec 1, 2021 Dec 3, 2021 Cartesian Therapeutics, Inc. CEO Sell 46.3 -4,746 -1.64% ✗ $14.1K
Oct 13, 2021 Oct 15, 2021 Cartesian Therapeutics, Inc. CEO Sell 42.5 -15,313 -5.21% ✗ $67.2K
Sep 1, 2021 Sep 3, 2021 Cartesian Therapeutics, Inc. CEO Sell 46.3 -4,523 -1.93% ✗ $20.4K
Jun 1, 2021 Jun 3, 2021 Cartesian Therapeutics, Inc. CEO Sell 46.3 -4,806 -2.11% ✗ $21K
Mar 1, 2021 Mar 3, 2021 Cartesian Therapeutics, Inc. CEO Sell 46.3 -5,461 -2.46% ✗ $23.3K
Dec 1, 2020 Dec 3, 2020 Cartesian Therapeutics, Inc. CEO Sell 46.3 -3,323 -3.17% ✗ $11.1K
Sep 1, 2020 Sep 3, 2020 Cartesian Therapeutics, Inc. CEO Sell 47.5 -3,364 -3.46% ✗ $8K
Jun 1, 2020 Jun 3, 2020 Cartesian Therapeutics, Inc. CEO Sell 46.3 -3,253 -3.64% ✗ $12.6K
Mar 1, 2020 Mar 3, 2020 Cartesian Therapeutics, Inc. CEO Sell 46.3 -3,374 -4.12% ✗ $13K
Dec 1, 2019 Dec 3, 2019 Cartesian Therapeutics, Inc. CEO Sell 46.3 -14,272 -16.75% ✗ $21.8K